The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

First tokamak plasma at the SMall Aspect Ratio Tokamak – SMART – recorded with a fast-framing camera in the visible spectral range. Credit: Universidad de Sevilla The University of Seville’s SMART ...

With the help of the implant, the man can control his wheelchair, operate the keyboard on his computer and use the cursor in such a way that he can even play chess. About a month after the ...